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ABSTRACT
Schimke immuno-osseous dysplasia is an autosomal recessive
genetic osteochondrodysplasia characterized by dysmorphism,
spondyloepiphyseal dysplasia, nephrotic syndrome and frequently
T cell immunodeficiency. Several hypotheses have been proposed to
explain the pathophysiology of the disease; however, the mechanism
bywhichSMARCAL1mutations cause the syndrome is elusive. Here,
we generated a conditional SMARCAL1 knockdownmodel in induced
pluripotent stem cells (iPSCs) to mimic conditions associated with the
severe form the disease. Using multiple cellular endpoints, we
characterized this model for the presence of phenotypes linked to the
replication caretaker role of SMARCAL1. Our data show that
conditional knockdown of SMARCAL1 in human iPSCs induces
replication-dependent and chronic accumulation of DNA damage
triggering the DNA damage response. Furthermore, they indicate that
accumulation of DNA damage and activation of the DNA damage
response correlates with increased levels of R-loops and replication-
transcription interference. Finally, we provide evidence that
SMARCAL1-deficient iPSCs maintain active DNA damage response
beyond differentiation, possibly contributing to the observed altered
expression of a subset of germ layer-specific master genes. Confirming
the relevance of SMARCAL1 loss for the observed phenotypes, they
are prevented or rescued after re-expression of wild-type SMARCAL1
in our iPSC model. In conclusion, our conditional SMARCAL1
knockdown model in iPSCs may represent a powerful model when
studying pathogenetic mechanisms of severe Schimke immuno-
osseous dysplasia.
KEY WORDS: DNA damage, DNA replication, Replication stress,
SIOD, IPSC
INTRODUCTION
Schimke immuno-osseous dysplasia (SIOD) is an autosomal
recessive genetic osteochondrodysplasia characterized by
dysmorphism, spondyloepiphyseal dysplasia, nephrotic syndrome
and frequently T cell immunodeficiency (Boerkoel et al., 2000;
Clewing et al., 2007; Saraiva et al., 1999). Patients usually suffer
from other less penetrant features and, depending on the severity of
the disease, they can undergo premature death in childhood or early
adolescence (Clewing et al., 2007). The disease is caused by bi-
allelic mutations in the SMARCAL1 gene (Boerkoel et al., 2002).
Although SMARCAL1 encodes for a protein homologous to the
SNF2 family of chromatin remodelling factors and SMARCAL1
has been involved in transcriptional regulation (Patne et al., 2017;
Sethy et al., 2018; Sharma et al., 2016), recent works proved that
SMARCAL1 is critical during processing of DNA structures at
replication forks to promote formation of replication intermediates
through its ATP-driven strand-annealing activity (Bansbach et al.,
2009; Ciccia et al., 2009).
Based on the pathophysiology of the disease, several hypotheses
have been proposed (Boerkoel et al., 2000; Elizondo et al., 2006);
however, the mechanism by which SMARCAL1 mutations cause
SIOD are completely unknown. The recent demonstration that
SMARCAL1 is crucial in response to perturbed replication, and that
recovery from replication stress is hampered by its loss or impaired
activity, challenged the canon for SIOD molecular pathology from
transcriptional regulation to DNA damage prevention. Thus, it is
tempting to speculate that SIOD phenotypes are linked to impaired
proliferation or development that could follow the accumulation of
DNA damage, similar to what has been proposed for other genetic
conditions caused by loss of genome caretaker proteins (Ciccia and
Elledge, 2010).
Many mutations in the SMARCAL1 gene have been identified,
ranging from frameshift and deletions, which generally lead to
protein loss, to missense mutations that differently affect expression,
activity, stability and localization of the protein (Boerkoel et al.,
2000; Elizondo et al., 2009). Interestingly, SIOD patients bearing
distinct SMARCAL1 mutations show a different degree of disease
severity (Elizondo et al., 2009). Thus, a phenotype-genotype
correlation might exist, although it is difficult to ascertain. Indeed,
mutations resulting in the almost complete loss of protein are
associated with severe SIOD. By contrast, mutations that similarly
affect SMARCAL1 ATPase activity give raise to both severe and
mild SIOD, arguing for the existence of genetic factors that can
modulate disease phenotypes or of additional ATPase-independent
SMARCAL1 functions that are affected by missense mutations
(Baradaran-Heravi et al., 2012; Elizondo et al., 2006, 2009).
Unfortunately, deletion of SMARCAL1 in mice or fruit flies fails
to fully recapitulate the SIOD disease phenotype (Baradaran-Heravi
et al., 2012). Only a study from zebrafish evidenced cellReceived 25 February 2019; Accepted 30 August 2019
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proliferation and developmental defects upon deletion of the
smarcal1 orthologue (Huang et al., 2010), suggesting that loss of
SMARCAL1 could affect proliferation and development in humans
too. Thus, although likely to exist, the correlation between
SMARCAL1 mutations, replication stress, DNA damage
formation, defects in proliferation and impaired development in
SIOD pathogenesis is as yet unexplored, largely because of the
inability of SMARCAL1 loss to induce all SIOD phenotypes in the
existing models of the disease.
Induced pluripotent stem cells (iPSCs) are useful when studying
the very first stages of development. Such a model system, although
unable to give a systemic view, is very useful for the identification of
early events associated with disease pathophysiology. Moreover, it
is genetically amenable and can be used to provide cell types for
drug screening.
Here, we generated iPSCs in which expression of SMARCAL1
could be downregulated through a Tet-ON-regulated RNAi system
to model severe SIOD. Using this cell model, we demonstrated that
depletion of SMARCAL1 resulted in reduced proliferation,
accumulation of DNA damage, replication defects and DNA
damage response (DDR) overactivation. Moreover, our data show
that the most striking phenotypes are correlated with increased R-
loop accumulation and can be reversed, preventing replication-
transcription interference. Most importantly, using our iPSC cell
model of severe SIOD, we established that replication-related DNA
damage also persists in differentiated cells and that loss of
SMARCAL1 affects expression of a subset of germ layer-specific
marker genes.
RESULTS
Generation and characterization of inducible SMARCAL1
knockdown iPSCs
To obtain an inducible model of severe SIOD, we expressed an
shSMARCAL1 cassette under the control of a Tet-ON promoter
through lentiviral transduction in the well-characterized normal
iPSC line WT I (Lenzi et al., 2015) (Fig. 1A). Low-passage iPSCs
were infected with the Tet-ON-shSMARCAL1 virus at 0.5 of
multiplicity of infection (MOI) by spinfection, selected and tested
for the knockdown efficiency by Western blotting. As shown in
Fig. 1B, culture of inducible SMARCAL1 protein knockdown
(iSML1) iPSCs with doxycycline (DOX) for 48 h resulted in less
than 20% of total SMARCAL1. Western blotting analysis of the
SMARCAL1 level after 7 or 14 days of continuing growth in DOX
revealed that the high knockdown efficiency was stable over time in
the iSML1 iPSCs (Fig. 1C).
As the goal of an iPSC model is to generate multiple
differentiated cell types, we next analyzed whether SMARCAL1
knockdown altered the expression of pluripotency genes. To this
end, cells grown for 7 days in the presence or absence of DOX were
analyzed for the expression levels of two key pluripotency genes
[NANOG and OCT4 (also known as POU5F1)] by real-time (RT)-
PCR. The analysis of gene expression showed that SMARCAL1
knockdown does not reduce the expression of the main pluripotency
marker genes (Fig. 1D).
Having demonstrated that continuous culturing in DOX-
containing medium is effective in maintaining downregulated
SMARCAL1, we analyzed whether depletion of SMARCAL1
affected proliferation in iSML1 iPSCs. To this end, iSML1 iPSCs
were grown in the presence or absence of DOX for up to 7 or from 7
to 14 days and the number of live cells recorded over time. Although
SMARCAL1 downregulation had little effect on proliferation of
iSML1 iPSCs during the first week after shSMARCAL1 induction
(Fig. 1E), it greatly impaired proliferation from 7 days of growth and
thereafter, as shown by the steady cell number and the reduced size
of colonies (Fig. 1E). The iSML1 iPSCs cultured in the presence of
DOX also exhibited a significant reduction in the number of
replicating cells, as evidenced by the decreased number of EdU-
positive cells, although no differences were observed between cells
grown in DOX for 7 or 14 days (Fig. 1F). No reduced viability or
replication was observed in naïve parental iPSC cultured in DOX
(Fig. S1A,B). Notably, re-expression of the wild-type RNAi-
resistant SMARCAL1 in iSML1 iPSCs through an inducible allele-
switch approach (see the schematic in Fig. S1C) largely reverted the
reduced EdU-incorporation (Fig. S1C,D). Reduced proliferation
and number of replicating cells were also observed in normal human
primary fibroblasts expressing the inducible shSMARCAL1
construct (Fig. S2A-C), suggesting that the phenotype is
independent of the cell cycle type and not specific to iPSCs.
Collectively, these results indicate that inducible long-term
depletion of SMARCAL1 in iPSCs is achievable. They also
demonstrate that depletion of SMARCAL1, a condition mimicking
the severe phenotype of SIOD cells, is associated specifically with a
time-dependent reduction in cell proliferation.
Depletion of SMARCAL1 induces DNA damage and
checkpoint activation in iSML1 iPSCs
Transformed or cancer-derived SMARCAL1-depleted cells are
characterized by elevated levels of DNA damage (Bansbach et al.,
2010; Ciccia et al., 2009; Couch et al., 2013). As inducible
SMARCAL1 downregulation hampers proliferation in iPSCs
(Fig. 1), we analyzed whether this phenotype could correlate with
enhanced DNA damage. To this end, we performed single cell
immunofluorescence analyses on the presence of two
acknowledged markers of DNA damage and checkpoint
activation, phosphorylated H2A.X variant histone (γ-H2AX) and
ATM (ATM-pSer1981). Depletion of SMARCAL1 by continuous
cell growth in DOX resulted in a significant increase in the number
of γ-H2AX-positive cells over time, which was otherwise not
observed in cells cultured in the absence of DOX or in naïve parental
iPSCs cultured in the presence of DOX (Fig. 2A; Fig. S3A,C).
Consistent with γ-H2AX data, depletion of SMARCAL1 also
triggered ATM activation, as visualized by enhanced Ser1981
phosphorylation (Fig. 2B), an event associated with DNA damage
and checkpoint activation. In contrast with γ-H2AX accumulation,
the presence of ATM-pSer1981-positive cells was constant between
7 and 14 days of culture in DOX, whereas it showed a small increase
over time in iSML1 iPSCs growing in the absence of DOX
(Fig. 2B). As shown for γ-H2AX accumulation, simply growing
parental iPSCs in DOX did not increase the level of ATM activation
(Fig. S3B,C). Increased activation of the DDR in the iSML1 iPSCs
was further assessed by western blotting using phosphospecific
antibodies for ATM and two of its downstream effectors, CHK2
(CHEK2) and KAP1 (TRIM28). Western blotting analysis
confirmed that a 14 day-long depletion of SMARCAL1 activates
the DDR and showed that long-term culturing in 1 µg/ml DOX does
not, per se, stimulate phosphorylation of the DDR factors (Fig. 2C).
To assess whether increased activation was related to loss of
SMARCAL1, we evaluated the presence of DNA damage and DDR
activation after re-introduction of the wild-type SMARCAL1.
Notably, expression of the RNAi-resistant wild-type SMARCAL1 in
the iSML1 iPSCs significantly reduced accumulation of γ-H2AX and
pATM foci (Fig. S4A,B). Although at a lesser extent than in iPSCs,
increased γ-H2AX and ATM-pSer1981 immunofluorescence was
also detected in normal human primary fibroblasts after inducible
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depletion of SMARCAL1 for population doublings corresponding to
14 days after shSMARCAL1 induction (Fig. S5A,B). Consistent
with the role of SMARCAL1 as replication caretaker (Bansbach et al.,
2009; Ciccia et al., 2009), the largemajority of iSML1 iPSCs staining
positive for γ-H2AX and pATM foci were from S-phase, although a
foci-positive staining was also observed outside S-phase (Fig. 3A,B).
These results indicate that continuous cell proliferation with
reduced levels of SMARCAL1 leads to DNA damage accumulation
and activation of proteins involved in the DDR. This phenotype is
directly related to loss of SMARCAL1 and cell-type independent,
but more striking in iPSCs than in primary fibroblasts.
Depletion of SMARCAL1 in iPSCs resulted in reduced fork
speed and defective replication
Having demonstrated that depletion of SMARCAL1 reduces
proliferation of iPSCs and increases DNA damage, we tested
whether it also affected DNA replication dynamics. To this end, we
performed single-molecule replication assays using dual-labelling
Fig. 1. Generation and characterization of inducible SMARCAL1 knockdown iPSCs. (A) Schematic representation of the experimental models.
iPSCs previously derived from human fibroblasts were infected with the inducible RNAi lentivirus. When challenged with 1 µg/ml doxycycline (DOX) for 7 days,
cells were considered SIOD. iPSCs were generated in the absence of DOX and, once established, shifted to aDOX+media. (B)Western blot showing the efficient
silencing of SMARCAL1 after 48 h treatment with DOX. Lamin B1 was used as loading control. (C) Western blot showing the long-term downregulation of
SMARCAL1 in DOX-supplemented medium. Lamin B1 was used as loading control. (D) Comparative analysis by qRT-PCR of the expression of pluripotency
markers NANOG and OCT4 after 7 days of DOX. Untreated iPSCs were used as reference sample. (E) Analysis of iPSC proliferation. Micrographs (left) show
different size of DAPI-stained colonies (blue) from iPSCs cultured in the presence or absence of DOX for the indicated time. Images are representative of different
fields. The graphs (right) show quantification of the number of live cells in each population evaluated at the indicated time-points. Student’s t-test was used for
statistical analyses. (F) Analysis of replicating cells in SMARCAL1-depleted iPSCs. Replicating cells were labelled with EdU for 30 min and the graph (left) shows
the percentage of positive cells (S-phase) after shSMARCAL1 induction. Representative images (right) show EdU-positive cells (red), with nuclear DNA
counterstained by DAPI (blue). Data are mean±s.e.m. from three independent experiments. **P≤0.01 (two-way ANOVA test). ns, not significant (P>0.05).
Scale bars: 20 µm.
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with halogenated thymidine analogues and DNA fibres (Leuzzi et al.,
2016). Active replication forks were labelled with two consecutive
5-chloro-2′-deoxyuridine (CldU) and 5-iodo-2′-deoxyuridine (IdU)
pulses of 15 min (Fig. 4A). To more accurately evaluate the presence
of fork obstacles accumulating with time, we also used a longer IdU
pulse (González Besteiro et al., 2019). Analysis of IdU track length in
dual-labelled fibres showed that loss of SMARCAL1 did not reduce
fork speed in iPSCs at 15 min, although it significantly decreased the
length of IdU tracks at 30 min (Fig. 4B). Thus, we analyzed the fork
symmetry, another parameter linked to the presence of stalled forks
(Técher et al., 2013), at 30 min of IdU labelling (Fig. 4C). Notably,
downregulation of SMARCAL1 resulted in an increasing number of
asymmetric bidirectional forks, as evidenced by a right/left fork ratio
higher than 1, where the right fork is showing the reduced length
(Fig. 4C).
Collectively, these results indicate that downregulation of
SMARCAL1 in iPSCs affects progression of DNA replication
with time, possibly inducing delay or stalling of a subset of ongoing
replication forks.
Preventing replication-transcription conflicts reduces DNA
damage and replication defects in SMARCAL1-depleted
iPSCs
Embryonic stem cells (ESCs) are characterized by reduced G1-phase
(White and Dalton, 2005), a condition reminiscent of cells with
activated oncogenes and correlated with enhanced frequency of
replication-transcription conflicts (Macheret and Halazonetis, 2018).
Hence, we tested whether increased DNA damage observed in
iSML1 iPSCs correlated with unresolved replication-transcription
conflicts. To this end, we grew iSML1 iPSCs in DOX for 7 days and
exposed cells to 5,6-dichloro-1-ß-d-ribofurosylbenzimidazole (DRB)
in the last 4 h before performing anti-γ-H2AX immunofluorescence.
DRB is a transcription inhibitor widely used to prevent replication-
transcription conflicts without affecting, in the short-term, proliferation
(Salas-Armenteros et al., 2017), and reduction of γ-H2AX levels in cells
treated with DRB indicates that DNA damage originates from
replication-transcription interference (Marabitti et al., 2019).
Downregulation of SMARCAL1 in iSML1 iPSCs elevated the rate
of DNA transcription as evaluated by 5-ethynyl-uridine (EU)
Fig. 2. Depletion of SMARCAL1 induces DNAdamage and checkpoint activation in iSML1 iPSCs. (A,B) The iSML1 iPSCswere cultured for 7 and 14 days in
the presence of doxycycline (DOX) to induce SMARCAL1 downregulation and then immunostained. The graphs (top) show quantification of the number
of γ-H2AX-positive cells (A) or ATM-pSer1981-positive cells (B). Representative images from triplicate experiments are shown (bottom). (C) Immunoblot detection
of the indicated DDR proteins in iSML1 iPSCs after 14 days of continuous treatment with DOX. Lamin B1 was used as the loading control. Data are mean±s.e.m.
from three independent experiments. *P≤0.05, **P≤0.01, ***P≤0.001 (two-way ANOVA test). ns, not significant. Scale bars: 10 µm.
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incorporation and click-it assay; however, 4 h of DRB treatment
similarly suppressed DNA transcription irrespective of DOX (Fig. S6).
Treatment with DRB did not significantly affect the presence of
γ-H2AX-positive cells in iSML1 iPSCs without DOX; however, it
substantially reduced their number in the presence of DOX (i.e. without
SMARCAL1) (Fig. 5A). Consistent with the γ-H2AX data, DRB
treatment also reduced ATM activation associated with SMARCAL1-
depletion (Fig. 5B).
An increased number of replication-transcription conflicts can be
associated with enhanced accumulation of R-loops (Hamperl et al.,
2017; Lang et al., 2017). To test whether R-loops accumulated after
SMARCAL1 downregulation in iPSCs, we purified genomic DNA
from cells treated with DOX for 7 days or not treated with DOX and
performed dot blot assays to detect R-loops using the S9.6 anti-RNA-
DNA hybrids antibody (Boguslawski et al., 1986; Hamperl et al.,
2017) (Fig. 5C). As shown in Fig. 5D, cells depleted of SMARCAL1
had substantially elevated levels of genomic R-loops, suggesting that
SMARCAL1 contributes to their prevention or resolution.
Accumulation of R-loops and replication-transcription conflicts
may underlie DNA replication defects. Thus, we evaluated
replication fork rate in iSML1 iPSCs cultured in DOX for 14 days
and treated or not treated with DRB for the last 4 h (Fig. 5E).
Interestingly, fork speed was unaffected by DRB treatment in
SMARCAL1-depleted cells (+DOX), although the fork symmetry
was recovered (Fig. 5F).
Therefore, loss of SMARCAL1 accumulates R-loops in iPSCs.
Furthermore, our results strongly suggest that DNA damage and
replication fork stalling, but not the fork slowing phenotype, depend
on accumulation of replication-transcription conflicts.
Increased levels of replication-dependent DNA damage and
checkpoint activation of SMARCAL1-depleted iPSCs persist
upon their differentiation
We demonstrated that sustained proliferation in the absence of
SMARCAL1 induces the accumulation of replication defects and
DNAdamage in iSML1 iPSCs. As SIOD affects different cell lineages,
we assessed whether the presence of such DNA damage would persist
also after spontaneous pluri-lineage differentiation of iPSCs.
To this end, iSML1 iPSCs were grown for 7 days in the presence of
DOX before switching from pluripotency maintenance medium to
differentiation conditions (Lenzi et al., 2015) (Fig. 6A). As shown in
Fig. 6B, SMARCAL1 knockdown was stable even in differentiated
cells. Consistent with its main function as replication caretaker, the
relative amount of SMARCAL1 in iSML1 iPSCs cultured without
DOX declined during differentiation. Next, we analyzed the presence
of DNA damage using anti-γ-H2AX immunofluorescence in the
population of differentiated iSML1 iPSCs. The number of γ-H2AX-
positive cells was very limited in the population cultured in the
absence of DOX, whereas it was much more elevated in cells with
DOX (Fig. 6C). Interestingly, immunofluorescence analysis of ATM
Fig. 3. Enhanced phosphorylation of H2AX and ATM is related to S-phase. (A,B) Analysis of the level of DNA damage in iSML1 iPSCs cells during
replication, at either 7 or 14 days. Cells were cultured in doxycycline+ medium as indicated and S-phase cells labelled with EdU for 30 min before sampling.
The graphs report the number of γ-H2AX-positive cells (A) or the number of ATM-pSer1981-positive cells (B) in the S-phase population. Data are means, from
biological duplicates. Standard errors are not depicted and are <15% of means. Representative images from 14 days are shown below the graphs; right
column, ATM activation; left column, H2AX phosphorylation. Scale bar: 10 µm.
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activation revealed a much greater difference between cells cultured
in the absence or presence of DOX (Fig. 6D). Irrespective of the
SMARCAL1 downregulation, the percentage of replicating cells,
evaluated using a 5-ethynyl-2′-deoxyuridine (EdU) incorporation
assay, was very low and similar at the end of the 15-days
differentiation protocol (Fig. 6E). Thus, differences in the number
of cells staining positive for the DNA damage markers are unlikely to
be related to an excess of undifferentiated replicating cells in the
iPSCs growing in the presence of DOX.
Our data indicate that chronic depletion of SMARCAL1 in iPSCs
stimulates the accumulation of persistent DNA damage and long-
term DDR activation, both replication-dependent events. This is
also seen in differentiated cells, in which replication is barely
detectable. To determine whether such persistent DDR would
interfere with pluripotency, we induced spontaneous differentiation
into the three germ layers, on a monolayer, and analyzed expression
of common marker genes by RT-PCR 15 days after the switch to
differentiation medium (KSR medium) (Fig. 7A). Analyses of germ
layer-specific genes showed that expression of brachyury (TBXT;
mesoderm), nestin (NES; ectoderm), AFP and NR2F2, an inhibitor
of OCT4 expressed early during human iPSC differentiation (Rosa
and Brivanlou, 2011), was altered in cells depleted of
SMARCAL1 (Fig. 7B). These changes in gene expression are
unlikely to be the result of spontaneous differentiation in
pluripotency conditions due to DNA damage, as no
downregulation of the pluripotency marker was observed in
DOX-treated undifferentiated cells (Fig. 1D). Changes in the
expression of these genes were not observed in the parental naïve
iPSC line cultured in the presence of DOX (Fig. S7). Interestingly,
re-expression of wild-type SMARCAL1 in the iSML1 iPSCs
reverted the effects of SMARCAL1 knockdown on brachyury,
nestin, AFP and NR2F2 (Fig. 7B,C). In these cells, alteration of
PAX6 and RUNX1 expression could be due to non-physiological
levels of SMARCAL1 (Fig. 7C).
Overall, these results indicate that accumulation of DNA damage
and increased DDR caused by loss of SMARCAL1 in
undifferentiated cells persist even after differentiation into the
progenitors of the three germ-layers, suggesting that the effect of the
loss of a replication caretaker may be ‘inherited’ by differentiating
cells. Moreover, our data suggest that expression of germ layer-
specific genes in iPSC-differentiated cells is affected by altered
SMARCAL1 levels.
Fig. 4. Analysis of DNA replication in
SMARCAL1-depleted iPSCs. (A)
Schematic of the labelling strategy. Cells
were labelled by two consecutive pulses of
the indicated halogenated nucleotides.
(B) The length of the IdU tracts (green; top)
was evaluated in at least 150 fibres after
15 min (left) and 30 min (right) and was
converted into fork speed values. The
graphs (bottom) show scatter plots of
single fork speed from iSML1 iPSCs
treated as indicated. ****P<0.0001 (Mann–
Whitney test). (C) Analyses of the fork
symmetry parameter evaluated as
indicated in the schematic (left). The graph
(right) shows the left/right fork value for
each bi-directional fork (n=100 from two
biological replicates; values on top
represent mean ratio for each population).
**P≤0.01 (two-way ANOVA test). Data are
mean±s.e.m. ns, not significant.
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DISCUSSION
Here, we demonstrate that conditional knockdown of SMARCAL1
in human iPSCs induces replication-dependent and chronic
accumulation of DNA damage triggering the DDR. We also
establish that DNA damage accumulation and DDR activation can
be maintained in SMARCAL1-deficient iPSCs after differentiation,
contributing to the altered expression of a subset of germ layer-
specific master genes.
Mutations in SMARCAL1 underlie SIOD (Boerkoel et al., 2002),
however how SMARCAL1 loss-of-function correlates with the
disease phenotype is unknown. Depletion of SMARCAL1 in
transformed cells has been reported to induce spontaneous DNA
damage and proliferation defects, which are accrued by induced
replication stress (Bansbach et al., 2009; Ciccia et al., 2009; Couch
et al., 2013). Similarly, patient-derived transformed fibroblasts are
characterized by high levels of DNA damage (Bansbach et al.,
2010). Our inducible SMARCAL1 iPSCs appear to recapitulate all
these phenotypes, showing the key cellular features of
SMARCAL1 loss: spontaneous DNA damage and replication
defects.
Of note, all animal models used to investigate SIOD pathogenesis
have failed to fully recapitulate the main disease phenotypes
(Baradaran-Heravi et al., 2012; Huang et al., 2010). Inducible PSCs
are powerful models for studying pathogenetic mechanisms of
diseases (Avior et al., 2016). In this regard, our inducible
SMARCAL1 knockdown iPSCs may prove useful for identifying
the molecular basis of SIOD, especially early molecular events.
Moreover, its allele-switch potential can be exploited to investigate
Fig. 5. Preventing replication-transcription conflicts reduces DNA damage and DDR in SMARCAL1-depleted iPSCs. (A,B) Analysis of accumulation of
DNA damage in iSML1 iPSCs after SMARCAL1 downregulation. Four hours before sampling, DRB was added in the indicated samples at 50 µM. The graphs
show the percentage of γ-H2AX-positive cells (A) or ATM-pSer1981-positive cells (B). Representative images are shown (bottom). Data are mean±s.e.m from
three independent experiments. *P<0.05, **P≤0.01, ***P≤0.001 (two-way ANOVA test). (C) Experimental scheme for the detection of R-loops by dot blot in
genomic DNA (gDNA). (D) Analysis of R-loop accumulation by dot blotting. Genomic DNA was isolated from iPSCs, treated or not with doxycycline (DOX)
to induce SMARCAL1 silencing, and then randomly fragmented before being spotted onto a nitrocellulose membrane. The control membrane was probed with
anti-RNA-DNA hybrid S9.6 monoclonal antibody. Treatment with RNase H was used as a negative control. (E) Schematic of the labelling strategy to detect
replication fork progression (top). Cells were labelled by two consecutive pulses of 30 min with the indicated halogenated nucleotides. DRB was added, where
indicated, 4 h before labelling. The graph (bottom) shows a scatter plot of single fork speed from iSML1 iPSCs treated as indicated. (F) The length of the IdU
tracts (green; top) was evaluated in at least 150 fibres. Ori, origin of replication. The graph (bottom) shows a scatter plot of the ratio between the right verses left
replication tract (green) from bidirectional forks as shown in the scheme on top. Values are from iSML1 iPSCs treated as indicated. Data are mean±s.e.m.
****P<0.0001 (Mann–Whitney test). ns, not significant. Scale bars: 10 µm.
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genotype-phenotype correlation vis à vis the reported involvement
of additional environmental, genetic and/or epigenetic factors in the
penetrance of SMARCAL1 mutations (Baradaran-Heravi et al.,
2012; Morimoto et al., 2016a).
SMARCAL1 is a replication caretaker factor and its loss-of-
function leads to perturbed replication forks (Couch et al., 2013).
Furthermore, ESCs and iPSCs are characterized by spontaneous
replication stress and accumulation of remodelled stalled forks
(Ahuja et al., 2016). SMARCAL1 is a crucial fork-remodelling
protein (Bétous et al., 2012; Kolinjivadi et al., 2017), and so its
function is expected to be more important in iPSCs or in ESCs than
in other specialized cell types. Indeed, our data show that both DNA
damage and activation of ATM increase over cell generation, and
mostly develop from S-phase cells. Consistent with this, the
proliferation potential of SMARCAL1 knockdown iPSCs does not
decline immediately after depletion, but a significant reduction is
observed a week after the induced inactivation of the protein. Such a
delay suggests that DNA damage or replication stress needs to reach
a threshold to induce proliferation arrest and is consistent with
increased activation of ATM over time. Of note, our data indicate
that conditional depletion of SMARCAL1 is sufficient to induce
DNA damage, ATM activation and reduced proliferation in both
primary fibroblasts and iPSCs. A telomeric function of SMARCAL1
has been also shown (Poole et al., 2015); however, the persistence of
these phenotypes in iPSCs, which re-express telomerase reverse
transcriptase (Takahashi et al., 2007), suggests that they are not
specifically related to telomere erosion and supports the presence of a
more genome-wide replication stress. Interestingly, persistence of
phenotypes in iPSCs also differentiate SMARCAL1 loss from that of
WRN, another critical replication caretaker (Franchitto and Pichierri,
2014). Indeed, the proliferation potential of cells from patients with
Werner syndrome is rescued after reprogramming (Shimamoto et al.,
2014). From this point of view, SMARCAL1-depleted iPSCs behave
more like those generated from FA-A cells, which are derived from
patients with Fanconi anaemia and retain all the key cellular defects of
the syndrome (Liu et al., 2014; Rosselli, 2003).
In PSCs, the most likely source of replication stress is linked to a
short G1 phase and increased origin firing (Ahuja et al., 2016; Ryba
et al., 2010). A similar mechanism for the generation of replication
stress has been put forward following oncogene activation
(Macheret and Halazonetis, 2018). Of note, in this case, most of
the replication stress would derive from interference between
replication and transcription (Macheret and Halazonetis, 2018).
Conditional knockdown of SMARCAL1 in iPSCs does trigger a
substantial accumulation of R-loops, which are linked to
replication-transcription conflicts (Hamperl et al., 2017; Lang
et al., 2017). This observation would suggest that SMARCAL1
counteracts accumulation of R-loops and replication-transcription
Fig. 6. Increased levels of replication-dependent DNA damage and DDR activation persist in SMARCAL1-depleted iPSCs upon their differentiation. (A)
Schematic of the early differentiation protocol of iSML1 iPSCs, treated with or without doxycycline (DOX) as indicated. (B) Western blot analysis of levels of
SMARCAL1 depletion after 7 and 15 days from spontaneous multi-lineage differentiation. Lamin B1 was used as loading control. (C,D) Analysis of DNA damage
accumulation or DDR activation in iSML1 iPSCs after spontaneous multi-lineage differentiation. The graphs (top) show the percentage of γ-H2AX-positive nuclei
(C) or ATM-pSer1981-positive nuclei (D) for each endpoint. Representative images are shown (bottom). (E) Analysis of replicating cells in SMARCAL1-depleted
iPSCs. EdU labelling (30 min) was used to mark replicating cells. The graph shows the percentage of EdU-positive cells after 15 days of early differentiation
treated or not with DOX. As reference, the values of EdU-positive cells in respect to the corresponding undifferentiated iSML1 iPSCs are included (d7). Data are
mean±s.e.m. from three independent experiments. *P<0.05, **P≤0.01 (two-way ANOVA test). Scale bars: 10 µm.
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conflicts, evidenced by the rescue of DNA damage and ATM
activation by transcription inhibition (Fig. 5).
The recent observation of a non-canonical ATM activation,
which is dependent on R-loop accumulation and alternative
processing (Tresini et al., 2015), and is increased upon defective
replication or mild replication stress (Marabitti et al., 2019), is
consistent with our data. Notably, although Smarcal1 knockout
mice do not have any significant proliferation defect, they show
a slow-growth phenotype and SIOD-related dysfunctions
if treated with α-amanitin (Baradaran-Heravi et al., 2012). As
α-amanitin interferes with the elongation phase of transcription
and not with its initiation, as occurs with DRB, it is possible
that slowing RNA polII increases the chance of replication-
transcription conflicts in Smarcal1 knockout mouse embryonic
fibroblasts, resulting in a proliferation defect as observed in our
iPSC model.
Interestingly, DNA damage and ATM activation caused by
replication-transcription interference in iPSCs depleted of
SMARCAL1 also persist after spontaneous differentiation in cells
of the three germ layers. Thus, a replication-dependent phenotype
appears to be inherited in differentiated cells. Most importantly, loss
of SMARCAL1 affects expression of a subset of germ layer-specific
master genes, which can be rescued through inhibition of DDR
signalling. The pathogenetic mechanisms responsible for SIOD are
still elusive; however, SMARCAL1 deficiency has been reported to
pathologically modulate gene expression (Baradaran-Heravi et al.,
2012; Morimoto et al., 2015, 2016a,b; Sanyal et al., 2015). An
intriguing possibility is that loss of SMARCAL1 function indirectly
influences gene expression through increased levels of replication
stress, as has been suggested for loss of WRN or FANCJ helicase
(BRIP1) (Khurana and Oberdoerffer, 2015; Papadopoulou et al.,
2015; Schiavone et al., 2014). Accumulation or persistence of
R-loops could be involved in this mechanism, suggesting the need
to assess whether R-loops preferentially accumulate at affected
genes. Of note, both ATR- and ATM-dependent signalling have
been found to be dysfunctional in cells lacking SMARCAL1,
especially following induction of DSBs by doxorubicin
treatment (Patne et al., 2017; Sethy et al., 2018). We, and
others, have found higher activation of ATM in the absence of
SMARCAL1 under unperturbed cell growth or upon perturbed
replication (Couch et al., 2013). Possibly, the function of
SMARCAL1 as promoter of ATM and ATR transcription, or as a
regulator of factors involved in the biosynthesis of long non-
coding RNA, is especially important in response to DSBs and
not upon replication stress.
One of the germ layer master genes showing increased expression
in SMARCAL1 knockdown iPSCs is brachyury. Notably,
expression of brachyury has been found to be elevated in
cordomas and correlates with increased cellular proliferation in
the bone (Miettinen et al., 2015), hence providing a possible link to
osseous dysplasia, which is one of the clinical phenotypes of SIOD
(Clewing et al., 2007).
Altogether, our work indicates that conditional downregulation of
SMARCAL1 in iPSCs recapitulates phenotypes observed in
specialized cells following SMARCAL1 depletion. Most
importantly, our study demonstrates that loss of SMARCAL1
Fig. 7. Alteration of SMARCAL1 affects expression of multi-lineage marker genes after differentiation of iPSCs. (A) Schematic of the early differentiation
protocol of iSML1 iPSCs. Gene expression was evaluated using q-PCR. (B) Comparative analysis by q-PCRof the expression of the indicated early differentiation
markers in iSML1 iPSCs. Relative gene expression represents data normalized to ATP5O and expressed relative to untreated iSML1 iPSC (DOX–) (n=6).
(C) Comparative analysis by qRT-PCRof the expression of the indicated early differentiationmarkers in iSML1 iPSCs induced to express RNAi-resistant wild-type
SMARCAL1 in combination with shSMARCAL1. Relative gene expression represents data normalized to ATP5O and expressed relative to untreated iSML1
iPSCs (DOX–) (n=3). Data are mean±s.d. *P<0.05, **P<0.01; ***P<0.001; ****P<0.0001 (multiple t-test analysis).
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induces the accumulation of DNA damage and ATM activation in
iPSCs through replication stress correlated with replication-
transcription conflicts. As mutations in SMARCAL1 cause the
multisystemic genetic disease SIOD (Boerkoel et al., 2002) and
complete loss of function of SMARCAL1 correlates with the
severest form of this condition (Elizondo et al., 2009), our
conditional knockdown of SMARCAL1 in iPSCs may represent a
powerful model for studying SIOD pathogenetic mechanisms and
complement other model systems in recapitulating the disease.
MATERIALS AND METHODS
Human iPSC culture, infection and differentiation
Human iPSCs used in this study belong to the WT I line described in Lenzi
et al. (2015), where they were authenticated (Lenzi et al., 2015). iSML1 iPSCs
were generated by spinfection of iPSCs (passage 13) with the lentiviral vector
Tet-ON-shSMARCAL1 at 0.5 of MOI. After 3 days, infected cells were
selected with 1 μg/ml puromycin and maintained under selection for
4 days. When indicated, 1 μg/ml doxycycline was added to the medium to
induce shSMARCAL1 expression. Established iSML1 iPSCs were
maintained in Nutristem-XF (Biological Industries) on plates coated
with hESC-qualified Matrigel (BD Biosciences) and passaged every 4-
5 days with 1 mg/ml dispase (Gibco). Cells were routinely screened for
mycoplasma infection.
For spontaneous pluri-lineage differentiation, 48 h after passaging the
culture mediumwas changed to KSRMedium (DMEM-F12, Sigma-Aldrich;
15%Knockout Serum Replacement, Thermo Fisher Scientific; 1× Glutamax,
Thermo Fisher Scientific; 1× Non-Essential Amino acids, Thermo Fisher
Scientific; 100 U/ml Penicillin+100 μg/ml Streptomycin, Sigma-Aldrich).
Medium was refreshed every other day until the end of differentiation.
Plasmid construction and transfection
The epB-Bsd-TT-SMARCAL1 construct was generated by inserting the
transgene sequence in the enhanced piggyBac transposable vector (Rosa
et al., 2014). The SMARCAL1 open reading frame (ORF) sequence was
amplified from the pLVX-IRES-Hyg-PGK-Flag-SMARCAL1 plasmid,
which was obtained by PCR cloning of the SMARCAL1 ORF into the
pLVX-IRES-Hyg-PGK vector obtained from Takara-Clontech. The
resulting construct was sequence-verified and contains the enhanced
piggyBac terminal repeats flanking a constitutive cassette driving the
expression of the blasticidin resistance gene fused to the rtTA gene and, in
the opposite direction, a tetracycline-responsive promoter element driving
the conditional expression of the transgene. iPSCs were co-transfected with
4.5 μg of transposable vector and 0.5 μg of the piggyBac transposase using
the Neon Transfection System (Life Technologies) as previously described
(Lenzi et al., 2015). Selection in 5 μg/ml blasticidin gave rise to a stable/
inducible cell line.
qRT-PCR analysis of differentiation markers
Total RNA was extracted using the Quick RNA MiniPrep kit (Zymo
Research) and retrotranscribed using the PrimeScript RT reagent kit (Perfect
Real Time). Targets were analyzed by qRT-PCR with SYBR Green Power-
UP (Thermo Fisher Scientific) in a 7500 Fast Real Time PCR System
(Thermo Fisher Scientific) and calculations performed with the delta delta
Ct method. The internal control used was the housekeeping gene ATP5O
(ATP5PO), ubiquitously expressed in human tissues. Primer sequences are
reported in Lenzi et al. (2015).
Growth curve
The cells were dissociated using Accutase (Gibco) and seeded at 2.0×104
cells per plate. Doxycycline induction after 48 h from seeding was
considered as the starting point of the growth curve. After trypsinization,
cells were counted through electronic counting cells (Bio-Rad) for the
following two weeks. After seven days, cells were counted, seeded again at
2.0×104 cells per plate and followed for up to 14 days. The growth curve of
the cell cultures was expressed as the number of live cells after Trypan Blue
staining as a function of time.
DNA fibre analysis
Cells were pulse-labelled with 25 μM CldU and then labelled with 250 μM
IdU with or without treatment, as reported in the experimental schemes.
DNA fibres were prepared and spread out as previously described
(Iannascoli et al., 2015). Images were acquired randomly from fields with
untangled fibres using an Eclipse 80i Nikon Fluorescence Microscope,
equipped with a Video Confocal (ViCo) system. A minimum of 100
individual fibres were analyzed for each experiment, and each experiment
was repeated three times.
Western blot analysis
Western blots were performed using standard methods. The antibodies used
are listed below. Blots were developed usingWestern-bright ECL (Advasta)
according to the manufacturer’s instructions. Quantification was performed
on scanned images of blots using Image Lab software, and values shown on
the graphs represent a normalization of the protein content evaluated
through lamin B1.
Antibodies
The primary antibodies used were: anti-SMARCAL1 (#ab154226, 1:1000;
Abcam), anti-pCHK2 (#2261, 1:1000; Cell Signaling Technology), anti-
CHK2 (#sc5278, 1:1000; Santa-Cruz Biotechnology), anti-pKAP1 (#A300-
767A, 1:1000; Bethyl Laboratories), anti-KAP1 (#A300-274A, 1:1000;
Bethyl Laboratories), anti p-ATM (#4526, WB 1:800; Cell Signaling
Technology), anti-pATM (#05-740, IF 1:300; Millipore), anti-ATM
(#NB100-104, 1:1000; Novus Biologicals), anti-pS139H2A.X
(#JBW301, 1:1000; Millipore), anti-LaminB1 (#ab16048, 1:20,000;
Abcam), rat anti-BrdU (anti-CldU, #ab6326, 1:60; Abcam), mouse anti-
BrdU (anti-IdU, #347580, 1:10; Beckton-Dickinson). HRP-conjugated
matched secondary antibodies were from Jackson ImmunoResearch and
were used at 1:40,000.
Immunofluorescence
Immunofluorescence microscopy was performed on cells grown on
coverslips. Briefly, cells were fixed with 4% paraformaldehyde and
permeabilized with 0.4% Triton X-100/PBS. After blocking, coverslips
were incubated for 1 h at room temperature with the indicated antibodies.
For detection of anti-BrdU, after permeabilization with 0.4% Triton X-100/
PBS, cells were denatured in 2.5 N HCl for 45 min at room temperature.
Alexa Fluor® 488 conjugated-goat anti mouse and Alexa Fluor® 594
conjugated-goat anti-rabbit secondary antibodies (Life Technologies) were
used at 1:200. Nuclei were stained with 4′,6-diamidino-2-phenylindole
(DAPI, 1:4000; Serva). Coverslips were observed at 20× objective with the
Eclipse 80i Nikon Fluorescence Microscope, equipped with a ViCo system.
Images were processed using Photoshop (Adobe) to adjust contrast and
brightness. For each time point at least 200 nuclei were examined. Parallel
samples incubated with either the appropriate normal serum or only with
the secondary antibody confirmed that the observed fluorescence pattern
was not attributable to artefacts. Experiments for labelling cellular DNA
with EdU or EU were performed by pulse labelling cells with EdU or EU
in culture media (10 µM) for 30 min. Detection was performed using
Click-iT EdU or EU imaging kits according to the manufacturer’s
specification (Invitrogen).
Dot blot analysis
Dot blot analysis was performed according to the protocol previously
described (Morales et al., 2016). Genomic DNA was isolated by standard
extraction with phenol/chloroform/isoamyl alcohol (pH 8.0) followed by
precipitation with 3 M NaOAc and 70% ethanol. Isolated genomic DNA
was randomly fragmented overnight at 37°C with a cocktail of restriction
enzymes (BsrGI, EcoRI, HindIII, XbaI) supplemented with 1 M
spermidine. After incubation, digested DNA was cleaned up using
phenol/chloroform extraction and standard ethanol precipitation. After
sample quantification, 5 μg of digested DNAwere incubated with RNase H
overnight at 37°C as a negative control. Then, 5 μg of each sample was
spotted onto a nitrocellulose membrane, blocked in 5% non-fat dry milk and
incubated with the anti-DNA-RNA hybrid [S9.6] antibody (ENH001,
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1:1000; Kerafast) overnight at 4°C. Horseradish peroxidase-conjugated
goat species-specific secondary antibody (sc-2031; 1:500; Santa Cruz
Biotechnology) was used. Quantification on scanned image of blot was
performed using Image Lab software (Bio-Rad).
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Salas-Armenteros, I., Pérez-Calero,C., Bayona-Feliu, A., Tumini, E., Luna, R. and
Aguilera, A. (2017). Human THO–Sin3A interaction reveals new mechanisms to
prevent R-loops that cause genome instability. EMBO J. 36, 3532-3547. doi:10.
15252/embj.201797208
Sanyal, M., Morimoto, M., Baradaran-Heravi, A., Choi, K., Kambham, N.,
Jensen, K., Dutt, S., Dionis-Petersen, K. Y., Liu, L. X., Felix, K. et al. (2015).
Lack of IL7Rα expression in T cells is a hallmark of T-cell immunodeficiency in
Schimke immuno-osseous dysplasia (SIOD). Clin. Immunol. 161, 355-365.
doi:10.1016/j.clim.2015.10.005
Saraiva, J. M., Dinis, A., Resende, C., Faria, E., Gomes, C., Correia, A. J., Gil, J.
and da Fonseca, N. (1999). Schimke immuno-osseous dysplasia: case report
and review of 25 patients. J. Med. Genet. 36, 786-789. doi:10.1136/jmg.36.10.786
Schiavone, D., Guilbaud, G., Murat, P., Papadopoulou, C., Sarkies, P., Prioleau,
M.-N., Balasubramanian, S. and Sale, J. E. (2014). Determinants of G
quadruplex-induced epigenetic instability in REV1-deficient cells. EMBO J. 33,
2507-2520. doi:10.15252/embj.201488398
Sethy, R., Rakesh, R., Patne, K., Arya, V., Sharma, T., Haokip, D. T., Kumari, R.
and Muthuswami, R. (2018). Regulation of ATM and ATR by SMARCAL1 and
BRG1. Biochim. Biophys. Acta Gene Regul. Mech. 1861, 1076-1092. doi:10.
1016/j.bbagrm.2018.10.004
Sharma, T., Bansal, R., Haokip, D. T., Goel, I. and Muthuswami, R. (2016).
SMARCAL1 negatively regulates C-Myc transcription by altering the conformation
of the promoter region. Sci. Rep. 5, 17910. doi:10.1038/srep17910
Shimamoto, A., Kagawa, H., Zensho, K., Sera, Y., Kazuki, Y., Osaki, M.,
Oshimura, M., Ishigaki, Y., Hamasaki, K., Kodama, Y. et al. (2014).
Reprogramming suppresses premature senescence phenotypes of Werner
syndrome cells and maintains chromosomal stability over long-term culture.
PLoS ONE 9, e112900. doi:10.1371/journal.pone.0112900
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K. and
Yamanaka, S. (2007). Induction of pluripotent stem cells from adult human
fibroblasts by defined factors. Cell 131, 861-872. doi:10.1016/j.cell.2007.11.019
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Figure S1. Naïve and wild-type SMARCAL1 iPSCs did not show reduced viability and 
replicating cells. 
(A) Analysis of live cells in naïve and iSML1 iPSCs. Cells were harvested at 7 and 14 days post-
treatment with doxycycline and stained with Trypan blue to discriminate live cells. Bar graph shows 
the percentage of live cells ± SE from three independent experiments. Statistical analysis was 
performed by ANOVA test, ns= not significant p>0.05; *P ≤ 0.05, **P ≤ 0.01.  (B) Analysis of 
replicating cells in naïve iPSCs. Replicating cells were labelled with EdU for 30min to stain S-phase 
and the graph plots the percentage of cells positive to EdU after 14 days treatment with doxycycline. 
Representative images are shown, nuclear DNA was counterstained by DAPI (blue). Statistical 
analysis was performed by ANOVA test, ns= not significant p>0.05; **P ≤ 0.01,   ***P ≤ 0.001. (C) 
Western blots analysis of SMARCAL1 expression after re-introduction of wild-type SMARCAL1 
and 14 days treatment with 0.3µg/ml Doxycycline. Lamin B1 was used as the loading control protein. 
(D) Analysis of S-phase cells in iSML1 iPSCs re-expressing wild-type SMARCAL1. Cells treated as 
in (B) were analysed for EdU positivity. The graph shows the percentage of cells positive to EdU 
signals, as control the values referred to the corresponding iSML1 iPSCs are included. Statistical 
analysis was performed by ANOVA test, ns= not significant p>0.05; **P ≤ 0.01, ***P ≤ 0.001. Scale 
bar represents 10µm. 
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Figure S2. Depletion of SMARCAL1 induced reduced proliferation in normal human primary 
fibroblasts 
A) Western blot showing SMARCAL1 depletion in primary fibroblasts after switching in Dox+
medium. Doxycycline was added a p14 and analysis was performed at p17 and p22. Lamin B1 is used 
for normalization. B) Evaluation of cell population size for wild-type and shSMARCAL1-induced 
primary fibroblasts. A starting culture of 6x104 cells was used to plate identical numbers of cells for 
each cell line and after 5 days in culture the total number of cells was recorded and reported in graph. 
Data are means±SE from two independent experiments. (**p<0.01; ANOVA test).  C) Evaluation of 
the proliferating population in wild-type and shSMARCAL1-induced primary fibroblasts. 
Doxycycline was added a p14 and analysis was performed at p17 and p22. Cells were cultured in 
IdU-containing medium in the last 24h before analysis. Graph shows the number of IdU+.  Data are 
from biological duplicates and are averages. Standard errors are not depicted and are < 15% of means. 
Representative images of the immunofluorescence experiment are shown.  Total DNA is stained with 
DAPI. Scale bar represents 10µm. 
Disease Models & Mechanisms: doi:10.1242/dmm.039487: Supplementary information
D
is
ea
se
 M
o
de
ls
 &
 M
ec
ha
ni
sm
s 
• 
S
up
pl
em
en
ta
ry
 in
fo
rm
at
io
n
Figure S3. The level of DNA damage and checkpoint activation did not increase in Naïve, 
parental, iPSCs. 
(A-B) Analysis of DNA damage and DDR in parental iPSCs. Doxycycline was added or not for 14 
days then cells were immunostained with anti-γ-H2AX or anti-ATM-pS1981 antibody. The graphs 
represent the analysis of positive cells, compared to shSMARCAL1 iPSCs. Statistical analysis was 
performed by ANOVA test, ns= not significant, ****P ≤ 0.0001.(C) Panel shows representative 
images of fluorescence fields from cells stained with anti-γ-H2AX or anti-ATM-pS1981 antibody 
(green) are provided. Total nuclear DNA was counterstained by DAPI (blue). Scale bar represents 
10µm. 
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Figure S4. Expression of the RNAi-resistant wild-type SMARCAL1 in the iSML1 iPSC reduced 
significantly accumulation of γ-H2AX and pATM foci. 
(A) Analysis of DNA damage accumulation after treatment or not with Doxycycline for 7 and 14 
days. The graphs show the percentage of positive nuclei for each indicated endpoint. Data are 
presented as mean ± standard error (SE) from two independent experiments. ns=not significant 
****P<0.0001; ANOVA test. Representative images from cells stained with anti-γ-H2AX (green) 
are shown. Total nuclear DNA was counterstained by DAPI (blue). (B) Cells as in (A) were analysed 
for DDR activation. The graph shows the percentage of positive cells for anti-ATM-pSer1981 
antibody. Statistical analysis was performed by ANOVA test, ns= not significant p>0.05; ***P ≤ 
0.001, ****P ≤ 0.001. Representative images of positive ATM-pSer1981 cells (green) are provided; 
nuclei were counterstained with DAPI (blue). Scale bar represents 10µm. 
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Figure S5. SMARCAL1-silenced primary fibroblast shows increased DNA damage and DDR 
activation 
A-B) Analysis of spontaneous DNA damage and DDR in primary fibroblast depleted for 
SMARCAL1. Doxycycline was added a p14 and analysis was performed at p17 and p22. Cells were 
immunostained with anti-γ-H2AX or anti-ATM-pS1981 antibody. The graphs represent the analysis 
of positive cells after continuous treatment with doxycycline at p17 and p22 (i.e. 7 and 12 days). 
Representative images of fluorescence fields from cells stained with anti-γ-H2AX or anti-ATM-
pS1981 antibody (green) are provided. Total nuclear DNA was counterstained by DAPI (blue). Data 
are from biological duplicates and are averages. Standard errors are not depicted and are < 15% of 
means. Scale bar represents 10µm. 
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Figure S6. Transcription inhibition prevents RNA synthesis in iSML1 iPSCs. 
Analysis of RNA synthesis in iSML1 iPSCs. Cells were labelled with 5'-Ethynil-Uridine (EU) for 1h 
to stain for active transcription. Four hours before sampling, DRB was added in the indicated samples 
at 50 µM. Cells were then fixed and subjected to Click-reaction to reveal EU. Dot plot shows the EU 
fluorescence intensity per cell measured after 14 days treatment with doxycycline. Representative 
images are shown, nuclear DNA was counterstained by DAPI (blue). Statistical analysis was 
performed by Mann-Whitney t-test, ****P ≤ 0.0001. 
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Figure S7. Minimal effects of doxycycline treatment on transcription of genes affected by 
SMARCAL1 alteration in iPSCs. 
Comparative analysis by qRT-PCR of the expression of the early differentiation markers shown in 
the graph in naïve iPSCs treated as in Figure 7A. Relative gene expression represents data 
normalized to ATP5O and expressed relative to untreated iPSCs (DOX-) (mean ± S.D.; n = 3. 
Multiple t-test analysis, *P< 0.05. Scale bars as indicated). 
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